Efgartigimod as rescue treatment in acute phase of neuromyelitis optica spectrum disorder: A Case Report
Introduction: Neuromyelitis optica spectrum disorder (NMOSD) is a central nervous system demyelinating disease. Current therapy methods, however, have limited effect on acute attacks except for intravenous methylprednisolone (IVMP). Efgartigimod is a first-in-class novel human immunoglobulin G1 (IgG...
Na minha lista:
| Principais autores: | , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier
2024-05-01
|
| 叢編: | Heliyon |
| 主題: | |
| 在線閱讀: | http://www.sciencedirect.com/science/article/pii/S2405844024064521 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|